Free Trial

DocuSign, Inc. (NASDAQ:DOCU) Position Raised by Sei Investments Co.

DocuSign logo with Computer and Technology background
Remove Ads

Sei Investments Co. grew its holdings in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 14.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 56,807 shares of the company's stock after acquiring an additional 7,215 shares during the period. Sei Investments Co.'s holdings in DocuSign were worth $5,109,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Toronto Dominion Bank raised its position in DocuSign by 30.3% in the third quarter. Toronto Dominion Bank now owns 26,159 shares of the company's stock valued at $1,624,000 after purchasing an additional 6,081 shares during the period. Quantinno Capital Management LP raised its holdings in shares of DocuSign by 39.5% during the 3rd quarter. Quantinno Capital Management LP now owns 201,546 shares of the company's stock valued at $12,514,000 after buying an additional 57,104 shares during the period. Rhumbline Advisers lifted its position in DocuSign by 118.8% during the 4th quarter. Rhumbline Advisers now owns 608,123 shares of the company's stock worth $54,695,000 after acquiring an additional 330,136 shares in the last quarter. KBC Group NV boosted its holdings in DocuSign by 32.7% in the 4th quarter. KBC Group NV now owns 1,535,107 shares of the company's stock worth $138,067,000 after acquiring an additional 378,233 shares during the period. Finally, Jennison Associates LLC acquired a new stake in DocuSign in the fourth quarter valued at approximately $12,897,000. Institutional investors and hedge funds own 77.64% of the company's stock.

Wall Street Analyst Weigh In

DOCU has been the topic of a number of recent research reports. Wells Fargo & Company boosted their target price on shares of DocuSign from $70.00 to $73.00 and gave the stock an "underweight" rating in a research report on Friday, March 14th. Robert W. Baird set a $93.00 target price on DocuSign in a research note on Friday, March 14th. UBS Group dropped their price objective on DocuSign from $100.00 to $90.00 and set a "neutral" rating on the stock in a report on Friday, March 14th. JPMorgan Chase & Co. upgraded DocuSign from an "underweight" rating to a "neutral" rating and increased their target price for the company from $70.00 to $75.00 in a research note on Monday, March 10th. Finally, Jefferies Financial Group dropped their price target on shares of DocuSign from $115.00 to $105.00 and set a "buy" rating for the company in a research note on Monday, March 31st. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, DocuSign has an average rating of "Hold" and an average target price of $95.83.

Remove Ads

View Our Latest Report on DocuSign

DocuSign Trading Down 6.7 %

DOCU traded down $5.16 on Friday, hitting $72.21. 2,881,620 shares of the company's stock were exchanged, compared to its average volume of 2,700,521. The stock has a fifty day moving average of $86.02 and a two-hundred day moving average of $82.35. DocuSign, Inc. has a twelve month low of $48.70 and a twelve month high of $107.86. The firm has a market cap of $14.62 billion, a PE ratio of 14.89, a P/E/G ratio of 6.94 and a beta of 1.20.

DocuSign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings results on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, topping analysts' consensus estimates of $0.84 by $0.02. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The business had revenue of $776.25 million for the quarter, compared to analysts' expectations of $760.94 million. During the same period in the prior year, the firm earned $0.76 EPS. The business's quarterly revenue was up 9.0% on a year-over-year basis. On average, analysts predict that DocuSign, Inc. will post 1.17 EPS for the current year.

Insider Transactions at DocuSign

In other DocuSign news, insider James P. Shaughnessy sold 7,500 shares of the company's stock in a transaction dated Tuesday, April 1st. The shares were sold at an average price of $81.31, for a total value of $609,825.00. Following the completion of the transaction, the insider now owns 45,875 shares in the company, valued at approximately $3,730,096.25. This represents a 14.05 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Peter Solvik sold 10,000 shares of DocuSign stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $91.26, for a total value of $912,600.00. Following the sale, the director now directly owns 150,253 shares in the company, valued at approximately $13,712,088.78. This trade represents a 6.24 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 57,851 shares of company stock worth $4,911,319. Insiders own 1.66% of the company's stock.

DocuSign Profile

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Recommended Stories

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Should You Invest $1,000 in DocuSign Right Now?

Before you consider DocuSign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.

While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

 5 Stocks to BUY NOW in April 2025

5 Stocks to BUY NOW in April 2025

March came in like a lion, and investors are hoping April brings a gentler outlook.

Recent Videos

5 International Stocks to Escape U.S. Market Volatility
MicroStrategy’s Bold Bitcoin Bet: Genius Move or Dangerous Gamble?
5 Big Reasons the S&P 500 Could Soar in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads